Corpus Intelligence IC Memo — COMMUNITY HOSP. MONTEREY PENINSULA 2026-04-26 11:18 UTC
IC Memo — COMMUNITY HOSP. MONTEREY PENINSULA
Investment Committee Memorandum | CA | 227 beds | Grade B | EBITDA uplift $58.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COMMUNITY HOSP. MONTEREY PENINSULA

CCN 050145 | MONTEREY, CA | 227 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

COMMUNITY HOSP. MONTEREY PENINSULA is a 227-bed suburban community hospital in MONTEREY, CA with $797.2M in net patient revenue and a 9.3% operating margin. The hospital serves a payer mix of 47.7% Medicare, 2.6% Medicaid, and 49.7% commercial.

Thesis: Platform Growth. Our ML models identify $58.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.3% to 16.6% (+736bps).

Net Revenue HCRIS$797.2M
Current EBITDA COMPUTED$73.9M
Operating Margin COMPUTED9.3%
Occupancy HCRIS70.1%
Revenue / Bed COMPUTED$3.5M
Net-to-Gross HCRIS31.2%
Distress Probability ML41.2%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
200
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 9.3% places it above the state median. Among 200 size-comparable peers (114-454 beds), the median margin is -3.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (114-454), prioritizing same-state peers. 200 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COMMUNITY HOSP. MONTEREY PENIN (Target)CA227$797.2M9.3%
RONALD REAGAN UCLACA446$2.62B-6.8%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UCI MEDICAL CENTERCA397$1.90B-2.5%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
RADY CHILDRENS HOSPITAL - SAN CA401$1.82B14.8%
HARBOR-UCLA MEDICAL CENTERCA369$1.54B-6.4%
EL CAMINO HOSPITALCA388$1.34B11.7%
CHILDRENS HOSPITAL OF ORANGE CCA334$1.31B0.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $58.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$16.7M+210bp18mo
Cost to Collect4.5%2.5%$15.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$15.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$9.7M+122bp9mo
Clean Claim Rate88.0%96.0%$510K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$16.7M
Cost to Collect
$15.9M
Denial Rate Reduction
$15.8M
A/R Days Reduction
$9.7M
Clean Claim Rate
$510K
Total EBITDA Uplift$58.7M
Current EBITDA$73.9M
+ RCM Uplift+$58.7M
Pro Forma EBITDA$132.6M
Current Margin9.3%
Pro Forma Margin16.6%
WC Released (1x)$30.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$113.7M$1.07B9.45x56.7%
Base (11x exit)10.0x11.0x$113.7M$1.22B10.72x60.7%
Bull Case9.0x11.0x$102.3M$1.45B14.17x69.9%
Bull (12x exit)9.0x12.0x$102.3M$1.61B15.75x73.6%
Bear Case11.0x10.0x$125.0M$743.8M5.95x42.9%
Bear (11x exit)11.0x11.0x$125.0M$858.8M6.87x47.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 200 hospitals with 114-454 beds
  • Same-state prioritization (n=201)
  • Comp margins: P25=-16.7% / P50=-3.9% / P75=4.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.